Drug Interactions Correction | The Medical Letter Inc.

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1162

August 4, 2003

View Complete Issue Table of Contents 2019

Drug Interactions Correction

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2003 Aug 4;45(1162):64

Disclosures

Objective(s)

Select a term to see related articles Celexa citalopram escitalopram fluoxetine fluvoxamine Lexapro Luvox MAO inhibitors Monoamine oxidase inhibitors paroxetine Paxil Prozac Selective serotonin reuptake inhibitors sertraline SSRIs Zoloft

SUMMARY: In the February 2003 update of the Adverse Drug Interactions Program and in the Handbook of Adverse Drug Interactions 2003, the potentially lethal interaction between selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs) was inadvertently omitted for citalopram (Celexa) and escitalopram (Lexapro). This interaction could occur with any SSRI.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.